Texas ChE Research Associate Jason Lavinder made key contributions to the country’s first peer-reviewed study on a promising COVID-19 treatment.
Posts Tagged ‘biomedical research’
COVID-19 Convalescent Plasma Therapy is Safe, With 76% of Patients Improving
Texas ChE Research Associate Jason Lavinder made key contributions to the country’s first peer-reviewed study on a promising COVID-19 treatment.
Maynard Teams Up With Synthetic Biologics To Fight Whooping Cough
Associate Professor Jennifer Maynard, the Laurence E. McMakin, Jr. Centennial Faculty Fellow, has teamed up with biotech company Synthetic Biologics, Inc. to develop a monoclonal antibody (mAb) therapy for the treatment of pertussis, commonly known as whooping cough.
Whooping cough causes an estimated 294,000 deaths annually worldwide, primarily among young, unvaccinated children. Recent reports … Read the rest »